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Abstract: Background: Antibiotic misuse and unsafe disposal harm the environment and human
health and contribute to the global threat of antimicrobial resistance. Household storage of
antibiotics for unsupervised use and careless disposal of medications is a common practice in
China and most low- and middle-income countries. Currently, few interventions are available
to address this challenge. Objective: This study assesses the feasibility and acceptability of an
evidence-based, theory-informed, community-based take-back programme for disposing household’s
expired, unwanted, or unused antibiotics in rural China. Methods: We adopted the RE-AIM framework
and the community-based participatory research principles in the development, implementation,
and evaluation of the intervention. The RE-AIM (reach, effectiveness, adoption, implementation,
and maintenance) and Medical Research Council’s frameworks were employed in analysing and
reporting evaluation results. A mixed-methods, controlled pre-and post-test design was used for (1)
quantitative surveying of a representative community panel of 50 households, and (2) qualitative
semi-structured stakeholders’ interviews to explore intervention and study design feasibility and
acceptability at three phases: pre-intervention, intervention, and post-intervention. Quantitative
and qualitative data from a similar village—serving as a control—were also collected. Results: All a
priori feasibility objectives were met: Conversion to consent was 100.0% (100 screened, approached,
recruited, and consented). All participants completed the pre-intervention assessment, and 44/50
households in the intervention village completed the post-intervention assessment. The programme,
embedded in existing social and physical infrastructure for dissemination, directly reached over 68.2%
(30/44) of its target audience. Stakeholders reported the intervention and study design as feasible and
acceptable. Conclusions: This study illustrates the feasibility, acceptability, and potential efficacy of
community-based antibiotic take-back programmes in China to encourage safe disposal and decrease
the availability of expired, unwanted, or unused antibiotics in the household for unsupervised use.
Keywords: drug take-back; environment; community health; drug abuse; prescription drugs;
antimicrobial resistance (AMR); RE-AIM; community-based participatory research (CBPR);
feasibility; pilot
1. Introduction
The effectiveness of antibiotics has been undermined by decades of antibiotic misuse constituting
a global health threat—antimicrobial resistance (AMR) [1,2]. In European countries, the burden of
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infections caused by antibiotic-resistant bacteria (170 DALYs per 100,000 population) is estimated to be
equal to that of the combined burden of three major infectious diseases including influenza, tuberculosis,
and HIV (183 DALYs per 100,000 population [3]. Comparatively, the prevalence of antibiotic resistant
infections in low-and-middle income countries (LMIC) such as Brazil and Indonesia is predicted to
rise 4–7 times faster than their European counterparts, leading to both economic and human cost [4,5].
A majority of human antibiotic consumption occurs in community settings outside of clinical facilities,
especially in LMIC where antibiotic self-medication is close to 40%; half of these antibiotics come from
household storage [6,7]. China, one of the world’s largest producers and consumers of antibiotics, faces
among the most severe challenges of this crisis, with antibiotic residues and resistance genes detectable
in surface water, waste water treatment plants, soil, vegetable produce, and animals [8–11]. Since 2011,
the Chinese government has implemented a series of measures to contain this problem; however, most
of these stewardship programmes focus on regulating prescriptions in hospitals and few address the
easy access to antibiotics available in communities [12,13]. Nationwide surveys demonstrated that
over 70% of Chinese households stored antibiotics that were eventually self-administered without
professional supervision [6,14–16].
Recent reviews showed expired, unwanted, or unused (EUU) medicines were either stored
unintentionally as leftovers or kept purposefully to treat similar conditions in the future (33%); among
those who disposed of unused medicines, 50% used a take-back programme and 42% disposed the
medicines in the trash or toilet [17–20]. The improper disposal of unused antibiotics can harm the
health of the environment, wildlife, and humans, especially in countries, like China, with poor waste
management systems [19]. The awareness and concern over the presence of pharmaceuticals in
drinking water and the threat of misuse posed by EUU medications has led to interventions like
’Wise List’ of medicines for ambulatory care [21] and drug take-back programs for the removal of
household access in developed countries (e.g., the United States, Sweden, and Germany) in the past
decade [18,22]. Evaluations of take-back events demonstrated their positive effect on raising awareness
about and reducing misuse or abuse of drugs [23–26]. “Ecopharmacovigilance” (EPV) has been
an area of novel interest in Europe and North America for the past decade with an aim towards
addressing issues associated with pharmaceuticals in the environment (e.g., water or soil) in a timely
and appropriate way [27]. The attention on EPV in China is recent, and focuses on minimization of
environmental risks posed by pharmaceutical residues and the need to guard against and control the
pharmaceutical pollution source [28–31]. However, despite being one of the largest producers and
consumers of antibiotics, discussions about safely disposing of antibiotics are practically non-existent
in China. No interventions to date have attempted to address non-prescription household antibiotics
use. There are few convenient and environmentally responsible disposal methods for systemically
removing or reducing household antibiotic stockpiles in China, and public-targeted interventions are a
pressing need.
In this study, we employed a mixed-methods approach to develop and assess the feasibility and
acceptance of an antibiotic take-back and disposal programme in rural China where antibiotic misuse
in the community is the most severe [32,33].
2. Results
Feasibility and Acceptability of the Intervention
Table 1 reports the socio-demographic and background characteristics of the study participants.
A total of 412 min of qualitative stakeholders interview data were collected (n = 21); each interview
lasted approximately 10–34 min. 19 out of 21 respondents were female; all but three did not go to
college. The mean age was 40.6 (±9.1) years.
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Table 1. Sample characteristics.
Intervention Control
Population Size 3015 1624
No. of Household 916 447






Woman 42 (84.0) 19 (90.5) 36 (72.0)
Man 8 (16.0) 2 (9.5) 14 (28.0)
Age
Minimum 23 24 22
Mean (SD) 45.8 (10.0) 40.6 (9.1) 49.1 (15.2)
Maximum 65 54 72
Highest Attainment
Education
College or above 3 (6.0) 3 (14.3) 7 (14.0)
High school 11 (22.0) 5 (23.8) 10 (20.0)
Middle school 24 (48.0) 10 (47.6) 17 (34.0)
Primary school or less 12 (24.0) 3 (14.3) 16 (32.0)
Income
>10,000 3 (6.0) 0 8 (16.0)
5001–10,000 16 (32.0) 6 (28.6) 9 (18.0)
3001–5000 17 (34.0) 12 (57.1) 16 (32.0)
<3000 14 (28.0) 3 (14.3) 17 (34.0)
Employment
Yes 21 (42.0) 9 (42.3) 11 (22.0)
No 29 (58.0) 12 (57.1) 39 (78.0)
Children in the
household
Yes 47 (94.0) 19 (90.5) 33 (66.0)
No 3 (6.0) 2 (9.5) 17 (34.0)
Having an active
WeChat account
Yes 40 (80.0) 32 (64.0)
No 10 (20.0) 18 (36.0)
How often do you use
WeChat?
All the time 27 (67.50) 27 (87.38)
Frequent 9 (22.50) 2 (6.25)
Sometimes 2 (5.0) 1 (3.13)
Not frequent 1 (2.50) 2 (6.25)
Never 1 (2.50) 0 (0.0)
Do you participate in the
waste sort and recycle
initiatives?
Yes 41 (82.0) 39 (78.0)
No 9 (18.0) 11 (22.0)
Have you ever used the
bartering market for
recyclables?
Yes 11 (22.0) 4 (8.0)
No 39 (78.0) 46 (92.0)
The quantitative evaluation data are presented in Table 2 where 44 households in the intervention
village and 39 households in the control village completed the post-intervention questionnaires with
no missing data. Pre-intervention baseline assessment showed that the most common method to
dispose expired, unwanted unused (EUU) antibiotics in the sampled villages was “thrown into garbage
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bin” (72%, 72/100), followed by “other methods” (8%, 8/100) and “stored in the house” (6%, 6/100),
indicating the need for appropriate disposal methods (Figure 1). During the 30-day intervention period,
roughly one third (7/22, 31.8%) of the households in the intervention village (who had self-reported
having antibiotics stored at home prior to intervention) returned the antibiotics. Additionally, a month
after the intervention, a follow-up assessment was conducted in pilot village to understand the change
in awareness and perceptions of the potential danger of “non-prescription antibiotic use” and “unsafe
disposal” on human and environmental health; 40 households in the intervention village completed
the follow-up questionnaire with one household skipped several items (missing data). Due to the
nature of the data and small sample size, these analyses are only useful for descriptive purposes.
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Figure 1. Methods to dispose expired, unwanted or unused (EUU) antibiotics.
Table 2. Awareness of the danger of antibiotic resistance and unsafe disposal and associated practices
among community panels.
Interventi n Components Intervention Village N (%) Control Village N (%)
PRE- POST- FOLLOW UP * PRE- POST- *
N = 50 N = 44 N = 40 N = 50 N = 39
Health education strategy
Knowledge and attitudes toward
self-medication with and disposal
of antibiotics
Antibiotic overuse may increase
antibiotic resistance
Agree 33 (66.0) 35 (79.5) 30 (75.0) 37 (74.0) 27 (71.1)
Neutral 11 (22.0) 6 (13.6) 9 (22.5) 12 (24.0) 8 (21.1)
Disagree 6 (12.0) 3 (6.8) 1 (2.5) 1 (2.0) 3 (7.9)
Inappropriat disposal of antibiotics
can harm th environment
Agree 45 (90.0) 42 (95.4) 37 (92.5) 40 (80.0) 31 (81.6)
Neutral 4 (8.0) 2 (4.6) 2 (5.0) 5 (10.0) 6 (15.8)
Disagree 1 (2.0) 0 1 (2.5) 5 (10.0) 1 (2.63)
Inappropriate disposal of antibiotics
can harm the environment, I will
dispose it appropriately
Agree 44 (88.0) 40 (90.9) 37 (92.5) 35 (70.0) 35 (89.8)
Neutral 10 (5.0) 4 (9.1) 2 (5.0) 10 (20.0) 2 (5.1)
Disagree 1 (2.0) 0 1 (2.5) 5 (10.0) 2 (5.1)
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Table 2. Cont.
Intervention Components Intervention Village N (%) Control Village N (%)
PRE- POST- FOLLOW UP * PRE- POST- *
N = 50 N = 44 N = 40 N = 50 N = 39
Inappropriate disposal of antibiotics
can harm the environment, I know
how to dispose it appropriately
Agree 29 (58.0) 28 (63.6) 27 (67.5) 21 (42.0) 20 (51.3)
Neutral 13 (26.0) 6 (13.6) 5 (12.5) 13 (26.0) 6 (15.4)
Disagree 8 (16.0) 10 (22.7) 8 (20.0) 16 (32.0) 13 (33.3)
Self-medication with antibiotics might
have an adverse impact on our health
Agree 41 (82.0) 44 (100.0) 34 (85.0) 44 (88.0) 32 (84.2)
Neutral 7 (14.0) 0 5 (12.5) 3 (6.0) 4 (10.5)
Disagree 2 (4.0) 0 1 (2.5) 3 (6.0) 2 (5.3)
Self-medication with antibiotics
might have an adverse impact on
health, one should not take antibiotics
without professional supervision
Agree 42 (84.0) 42 (95.6) 31 (79.5) 38 (76.0) 29 (74.4)
Neutral 4 (8.0) 0 4 (10.3) 8 (16.0) 5 (12.8)
Disagree 4 (8.0) 2 (4.6) 4 (10.3) 4 (8.0) 5 (12.8)
Self-medication with antibiotics
might have an adverse impact on our
health, one should not store
antibiotics at home
Agree 24 (48.0) 30 (68.18) 18 (46.1) 26 (52.0) 24 (63.2)
Neutral 12 (24.0) 6 (13.6) 7 (18.0) 12 (24.0) 10 (26.3)
Disagree 14 (28.0) 8 (18.2) 14 (35.9) 12 (24.0) 4 (10.5)
Participation in the antibiotic
take-back programme
Household antibiotic storage at the
time of survey
Yes 25 (50.0) 22 (50.0) 18 (45.0) 17 (34.0) 8 (21.1)
No 25 (50.0) 22 (50.0) 22 (55.0) 33 (66.0) 30 (78.9)
Participation in the take-back
programme
Yes - 7 (31.8) 6 (33.3) - -
No - 15 (68.2) 12 (66.7) - -
* Some items had missing data from one household. - no participation data collected from pre-intervention
assessment and the control group.
Recruitment and retention: Fifty households in each study site were approached; all were eligible
and recruited. The proportion of households approached who consented (conversion to consent) was
100%—well above the target set of 60.0%. Among them, 44 in the intervention village and 39 in the
control village retained and completed the pre- and post-intervention questionnaires.
Reach is measured by the percentage of residents who were informed about the programme and
were potential users. Thirty out of forty-four households in the community panel had heard of the
antibiotic take-back programme. A total of 13.3% had heard about it from WeChat and Women’s
Federation, over 90% from print materials.
Effectiveness is measured by participation in or intention to participate in the take-back programme.
A total of 48 households used the bartering market (7 households from the community panel).
Thirty-eight households intended to participate in the future and eight already recommended using
the bartering market for antibiotic take-back to at least one other person in the past month.
Adoption: No barriers to adoption were identified by implementers. Not knowing about the
take-back programme, no household storage, and no time to bring antibiotics in were listed as
Antibiotics 2020, 9, 212 6 of 16
the top three reasons for non-participation by the community panel. Additionally, 34 households
said they would recommend other villages to adopt the antibiotic take-back programme in their
bartering markets.
Implementation of the programme, measured by fidelity, was delivered as intended. All eligible
Women’s Federation members were actively involved in intervention delivery. A total of 48 households
used the bartering market for antibiotic take-back and disposal; all returned antibiotics were properly
sorted and documented according to study protocol, reported in Table 3. Intervention adherence and
participant compliance was achieved.
Maintenance concerns the long-term maintenance of behaviour change at the individual level,
which is not assessed in this study. At the village level, the potential for the antibiotic take-back
programme to become a routine part of the culture is high. Among the 44 households who completed
the post-intervention assessment, 40 interviewees thought the take-back programme should stay a
part of the bartering market and be promoted to other villages, 4 stayed neutral, and none disagreed.
Acceptability and appropriateness: The acceptability and appropriateness of the intervention
is high. Awareness around the environmental protection is high. The intervention was appropriate,
acceptable and sustainable to the implementers, the Women’s Federation. Additionally, among the four
households in the control village that had heard of the take-back programme, two reported intention
to participate, which will indicate scalability.
Process evaluation outcomes are reported in Table 3. In brief, a total of 50 boxes of antibiotics were
collected during the first 30 days of the programme, valued at 592 RMB worth of household items at the
bartering market—an average of 11.84 RMB per box. Health education messages were disseminated
via WeChat (no cost), SMS and posters and pamphlets (approximately 1200.00 RMB). 34 respondents
mentioned “to protect the environment” as the main reason to continue or to expand the bartering
market for antibiotic-take back, 18 “to prevent inappropriate use at home”, and 12 “because there is no
other platform to safely dispose antibiotics", while 10 respondents felt “incentivized by the household
items at the bartering market”.
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Table 3. Process evaluation on the antibiotic take-back programme.
Quantitative Data
Health Education Strategy
No. of households in the intervention village completed post-evaluation 44 households
No. of households received the health education messages 30/44 households (68.2%)
No. of households further spread this message 8/30 households (26.7%)
Bartering Market for Household Expired, Unwanted, or Unused (EUU) Antibiotics
No. of households participated in the bartering market (including those who are not
in the community panel) 48 households
Antibiotics take-back via the bartering market No. of box












Total no. of returned antibiotics (boxes)/total costs 50 boxes/RMB 592




1. I have seen health education materials and realized that overuse of antibiotics can cause harm to the human
body.
• “It is written on the leaflet that it is not good to take too much of it, so I brought it here.”
(Male, 65 years old, primary school)
• “In the past, I would put some medicine at home, and I would take it when I subsequently got sick. I think the
doctors actually prescribe more or less the same medication, but after reading the leaflet, I felt these materials
are very useful. It is bad to take too much of it, and you can’t do this either. It has to be placed at the recycling
point.”
(Female, 42 years old, high school graduate)
1. I saw the relevant materials but was too late to take them to the
bartering market.
• “Recently, it was really busy at home. I didn’t have time
to take it there. In the future, if I have time here, I will
take it there. It [the bartering market] is just a stone’s
throw away, so it is very convenient.”
(Male, 48 years old, high school graduate)
2. Throwing antibiotics anywhere can pollute the environment. They are better handled by the bartering
market.
• “The medicine is left at home, and it will be thrown away after a long period time. [I learned that] It will
pollute the environment, so I brought it to the bartering market after seeing the ad.”
(Male, 65 years old, primary school graduate)
• “It is not good to throw medicine as one pleases. You can’t throw them away randomly. After reading the text
messages carefully, I felt there was something to gain.”
(Male, 62 years old, middle school graduate)
• “I saw a notice saying that throwing medicine along with other garbage would pollute the environment. The
bartering market is very good and can be taken advantage of.”
(Female, 40 years old, middle school graduate)
2. There is no reserve of antibiotics at home.
• “We are usually in Wenzhou; there are no antibiotics at
home. I don’t really like keeping too much medicine at
home.”
(Female, 29 years old, high school graduate)
• “We have no medicine at home, but after reading this
material, I will be willing to take it there in the future.”
(Male, 43 years old, high school graduate)
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Table 3. Cont.
3. There is no use keeping it at home. There are even gifts redeemable at the bartering market.
• “It is useless for me to keep medicine at home. The bartering market is quite good, and there are even
redeemable gifts there, so they can be taken advantage of.”
(Female, 40 years old, middle school graduate)
3. No relevant health education materials were received.
• “I didn’t receive the text messages. It may be that there
was something wrong with the mobile phone. We are
already old, so we don’t always check our mobile phones. I
don’t know where the leaflet was placed; it could no longer
be found.”
(Female, 49 years old, middle school graduate)
4. I don’t know how to handle it correctly myself.
• “I seemed to have set it up for a period of time before, but no one put it there. We usually just keep it at home,
and I am worried that the children will take it randomly. If there is a recycling point, it will be more convenient
because one can just put it directly there. Directly throwing antibiotics into an ordinary trash can doesn’t seem
too good either, but we don’t know how to deal with it.”
(Female, 33, high school graduate)
4. If something remains, I can use it next time. I am not very
willing to take it there.
• “I also know that if it is just a small illness, one just needs
to rest a few days even without taking medication to get
well. But when one goes to work, they cannot rest for
several days. I have to keep the medicine for use in the
future. I don’t want to buy medicine again. The
symptoms are similar every time. And the medicine
prescribed by the doctor is more or less the same. Just
taking the same medicine as last time is enough; taking
medicine makes one recover faster. And some medicines
have one or two left, and I would be embarrassed to take
them there in exchange for a gift.”
(Male, 31 years old, college graduate)
Acceptability of the
Incentives
• “I think that ordinary soap, scented soap, toothpaste and other similar things can be used, it would be very
good, I personally like it.”
(Female, 42 years old, high school graduate)
• “As regards gifts, it’s hard to say. Personal needs are different, and more choices are better.”
(Female, 40 years old, middle school graduate)
• “Some medicines have one or two pieces left, and I would
be embarrassed to take them there in exchange for a gift.”
(Male, 31 years old, college graduate)
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Data that address 14 methodological issues of feasibility research for full-scale intervention
development are presented in Table 4.
Table 4. Summary of the findings against 14 methodological issues for feasibility research.
Methodological Issues Findings Evidence
1. Did the feasibility study allow a





50 households consent to participate in the
study
48 households used the bartering market; 7
households were from the panel
2. What factors influenced eligibility
and what proportion of those
approached were eligible?
All households were eligible All households were eligible
3. Was recruitment successful? Yes 50/50 (100%) households agreed to participatein the panel
4. Did eligible participants consent? Good conversion to consent Fifty recruited out of 50 eligible, consent rateof 100.0%
5. Were participants successfully
randomised and did randomisation
yield equality in groups?
Not applicable in this study Not applicable in this study
6. Were blinding procedures adequate? Not applicable in this study Not applicable in this study
7. Did participants adhere to the
intervention?
Good adherence to the
protocol
All take-back antibiotics were returned and
documented according to the protocol.




Residents from the intervention and control
sites and the implementers found the
intervention acceptable
9. Was it possible to calculate
intervention costs and duration? Yes
Costs for resource utilisation were assessed
for participant use of antibiotic take-back
programme and in-kind wage of
implementors
10. Were outcome assessments
completed?
There was no missing data
from the take-back bartering
market or from the household
surveys.
There was no missing data as outcome data
were collected in person.
11. Were the outcomes measured the
most appropriate outcomes?
Outcome measures used did
assess main outcomes of
interest
Bartering market use data, household
antibiotic stocks, and returned antibiotic were
documented and analysed.




13. Were the logistics of running a
cluster randomised controlled trial
addressed?
The buy-in from the Women’s
Federation on site positively
influenced the logistical
running of study
There were no difficulties identified in the
various processes and the researcher’s ability
to implement them. Residents once recruited
were readily identified.
14. Did all components of the protocol
work together?
There were no difficulties
identified in the various
processes and the researcher’s
ability to implement them.
Residents and the implementer (i.e. the
Women’s Federation) found the intervention
acceptable, feasible, and easy to implement.
3. Discussion
This study presents the high feasibility and acceptability of a community-based antibiotic take-back
service offered at a local bartering market for recyclables. The overall positive feedback supports the
need and warrants the continuation and expansion of the programme. There is a lack of environmentally
safe disposal guidelines and take-back services for the proper disposal of antibiotics in China. This
proposed intervention served a dual-purpose: (a) To reduce access to unnecessary antibiotics in the
household and the likelihood of self-medication with antibiotics without supervision, and (b) to
promote safe disposal and protect the environment. Villagers confirmed the existing local town-run
bartering market for recyclables as a convenient site for an antibiotic disposal programme. These
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bartering markets are often located in village centres accessible to most residents and managed by local
officials or members of local Women Federation chapters, well-known to the community. As such, the
costs (approximately 1800.00 RMB) were minimal when the proposed intervention was well-embedded
in existing infrastructure, which further improved feasibility and scalability. Our data showed removal
of household antibiotic storage can reduce the likelihood of self-medication with antibiotics.
Strengths of this study include utilisation of a mixed-methods approach and adoption of the
RE-AIM and MRC evaluation frameworks to achieve the study aims. Also, by following the
community-based participatory research (CBPR) principles, this project had two distinctive features:
Local ownership and a realist approach throughout the adaptation and implementation process. First,
the community partners were involved in plans and development from the beginning and had real
influence on the project; their involvement helped to develop the understanding of the “contexts”
and “mechanisms” that constitute the effectiveness of behavioural change interventions. Second,
with RE-AIM constructs embedded in the study design since project inception, we were equipped to
identify “what works for whom, in what contexts, and how”. The findings from this study should
be interpreted with several limitations. The small sample and use of one site may seem to limit the
results’ generalisability. Because data were collected from a representative sample of rural Chinese
residents in the participating site, representing 5.5% (50/916) of the households, and from a control
site (11.2%, 50/447) at three different time points, the general pattern of findings observed in this
study is sufficiently robust for a feasibility study to alleviate concerns about potential spuriousness.
This investigation offers needed empirical feasibility data on the antibiotic take-back programme for a
large trial.
Interpretation of Findings
This study identified a critical gap of current AMR strategy in the Chinese infrastructure where
EUU antibiotics in the community are left unattended. There is a lack of knowledge of and platform
for proper disposal and a strong interest in participating in take-back programmes. Formative data
found that the local awareness and concern over the presence of pharmaceuticals in drinking water
and the threat of misuse were high in both intervention and control villages, yet self-medication
with antibiotics were common among local residents who seemed to be unsure of what constitutes
proper disposal and showed reluctance in giving up habits of household storage of antibiotics.
We found individual’s health decisions about antibiotic use to be complex and not entirely driven
by their cognitive and rational characteristics—contextual factors, including access to antibiotics
and interpersonal connections, are equally or more critical to healthcare decision-making processes.
Evidence showed when information or time is limited and complexity of the situation is overwhelming,
individuals often combine rationality with other sources of so-called tacit or experiential knowledge
and utilise strategies such as trust, intuition, and emotion to assist decision making [34]. Antibiotic
misuse in China is driven by a complex set of factors embedded in its culture and beliefs, health
system, and society [13,16,35]. Data from this project highlighted that increasing knowledge and
raising awareness about the consequences of the inappropriate use and disposal alone is unlikely to
enable the desired behaviour change. A complex intervention that also supports prudent prescriptions,
reduces over-the-counter purchases, and improves dispensing systems to reduce leftover prescriptions
in addition to the proposed community-based intervention will be necessary. Further clarifications
about what constitutes “appropriate practices” in the given context should be included in the education
intervention. In our sampled villages, respondents who engaged in misuse behaviours such as feeding
children with antibiotics, burying them in the field, taking them before expiration, or not thinking
antibiotics can “go bad” might consider their behaviour as “being completely appropriate”. Changing
the local social and infrastructure environments for appropriate antibiotic use and disposal while
providing actionable information about how and when/where to use and dispose antibiotics are key to
cue people to action. Educating about how to care for common self-limiting illnesses and non-antibiotic
alternatives for symptom relief will improve the likelihood for better use of antibiotics. Health
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education messages for the project should address these concerns during full scale implementation.
This study also informed sampling and data collection strategy during full scale implementation. We
found that many younger adults of a working age stayed away during the week for work, leaving
only grandparents and children in the village; it was therefore best to reach them over weekends.
This scenario has important implications on the planning of data collection when large sample size is
involved as it restricts the number of days allowed for data collection. Furthermore, it is concerning
that within 30 days, we saw a sharp decrease in the household antibiotic storage in the pilot village
from 34.0% to 27.8% in the absence of an intervention. There might be several possible explanations
for this phenomenon: for example, a Hawthorne effect (also referred to as the observer effect) in which
individuals modify their habits of storing antibiotic at home in response to their awareness of being
observed. However, we ruled out this possibility because this effect was not seen in the intervention
village which was also being observed. Also, formative data suggested that unlike prescription
drug diversion in the U.S. which might be viewed as a type of behavioural disorder carrying a
potential social stigma [36], in China keeping antibiotics at home for future use is a socially acceptable
common practice [37,38]. The concern over under-reporting of household storage of antibiotics is
low. Furthermore, the quantity of household storage of antibiotics was verified by an inspection of
the household medical cabinet onsite, leaving little room for error in reporting. A small sample size,
a short study duration, or the timing of data collection (e.g., flu season or not) may also be variables in
play. However, this speculation could not fully explain the sudden drop in the storage observed in
the control village, which calls for further qualitative investigation. On the other hand, since there is
currently no mechanism in place to remove the excess antibiotics from these households, the reduction
in the storage can only be assumed to either have been consumed without a prescription or discarded
inappropriately. This discovery was worrisome, especially considering the timing of the feasibility
study (June) was not peak season for upper respiratory tract infections (URTIs) and was low season
for antibiotic consumption. Given this timing, compounded with easy access to antibiotics and the
population size of 577 million rural residents, it is clear that the severity of misuse and mishandling
of antibiotics in the community requires an urgent need for intervention. Nevertheless, during the
30-day period, this programme was able to reach a sizable portion (68.2%, 30/44) of the intended target
audience with messages promoting the safe disposal of antibiotics, and among them, 26.7% (8/30)
further spread this message, including people outside of the intervention villages.
The frequent exchange of information between villages reported in this study also indicated that in
a full-scale study, township-level randomisation—rather than village-level—would be appropriate as
part of a cluster trial. Choice of sampling approach (e.g., “fried-egg” design [39]—sampling individuals
from villages centrally located within each township) will need to be handled with care to prevent
“contamination” between intervention and control groups. Future research on social networks may
be able to generate additional insight regarding the diffusion of innovations for reducing antibiotic
misuse. Moreover, given the high levels of antibiotic residues in fresh water and soil in China, future
studies should explore whether those more conscious about environmental protection are more likely
to engage in prudent antibiotic use and disposal, which may inform a “One Health” approach. Finally,
we recognise that although the proposed intervention will remove household antibiotic stockpiling,
it will not address all the challenges associated with antibiotic misuse in the community. For example,
community pharmacies have been identified as the main source of antibiotics for self-medication in
China [7] despite a national policy that bans non-prescription sale of antibiotics. Future intervention
could include pharmacists as antibiotic stewards [40,41] and train them to better advise consumers
on safe disposal of EUU antibiotics and the responsible management of self-limiting URTIs such as
offering alternative symptom relief options for the common cold or flu. A multifaceted complex
intervention that also enforces regulations regarding the sale of antibiotics and pack-based antibiotic
dispensing systems to reduce leftover antibiotic prescriptions is necessary to curb the main sources of
non-prescription antibiotics for self-medication use.
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This study filled the knowledge gap by describing systematic steps taken to adapt
community-based interventions for a new context and a new health risk. From a global health
perspective, the results of this study demonstrate that a take-back programme can be a potentially
effective instrument for decreasing the availability of unnecessary antibiotics and potential misuse in
communities across China and around the world, especially in low-and-middle income countries. As
most rural Chinese towns have bartering markets, the proposed intervention has great potential for
significance and scalability.
4. Methods
This study aims to determine the feasibility and acceptability of the proposed intervention,
an antibiotic take-back programme in rural China. The proposed intervention consists of two
components: A community-based antibiotic take-back programme (embedded in the existing
“bartering market” for recyclables in rural Zhejiang province) and health education. We first pre-tested
intervention materials and implementation methods with experts and potential users for validity and
appropriateness. Second, we explored stakeholders’ views on potential facilitators and barriers to
the intervention. Last, utilising a mixed-methods design, we assessed the feasibility, acceptability,
and scalability of a pilot intervention and explored its effectiveness. The study design and process of
adapting existing interventions to new populations and settings are reported in detail elsewhere.
4.1. Feasibility Study Design
Guided by the Medical Research Council’s (MRC) framework for the development and evaluation
of complex interventions [42] and the RE-AIM (reach, effectiveness, adoption, implementation, and
maintenance) framework [43], this mixed-methods research design comprised a controlled pre–post
quantitative component and embedded qualitative component. The study methodology’s feasibility
was first examined using the following quantitative data: Recruitment, retention, follow-up measure
response rates, missing follow-up measure data, and usage data. The study design and intervention’s
feasibility and acceptability were then explored using qualitative semi-structured interviews with
stakeholders. We noted that this pilot study was designed to test the feasibility of one component of a
large community-based complex intervention, not the efficacy or effectiveness of the new intervention,
which is the aim of a full-scale randomized controlled trial (RCT) [44]. Lastly, we systematically
explored and addressed the 14 potential methodological issues of feasibility studies identified by
Bugge et al. and Shanyinde et al. [45,46].
4.2. Setting and Sample
Feasibility data for the intervention came from a representative community panel of 100 households
in two rural villages—one intervention and one control—in Zhejiang, China, conducted over the first
30 days of implementation of an antibiotic take-back programme in June 2019. All households in the
villages were eligible for inclusion and those agreeing to participate gave informed consent. Due to the
intervention design and the local context, we targeted the self-identified female heads of household.
Qualitative data came from 21 purposively-selected stakeholders of the community, who represented
the characteristics relevant to the study setting in terms of age, gender, socio-economic status, and
community roles.
4.3. Data Collection and Management
For pre- and post-intervention evaluations with the community panel, face-to-face household
surveys consisted of quantitative and qualitative items assessing antibiotic use and disposal behaviours,
exposure to and participation in the programme, and public knowledge and perceptions about antibiotic
use. Inspections of household medical cabinets were conducted at the end of each survey. Stakeholders,
including residents, local government officials, community partners, potential implementers of
the intervention, community pharmacies and clinicians, and local residents, were recruited for
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semi-structured interviews and to access process evaluation data in the pilot village. Pre- and
post-intervention evaluation data—both quantitative and qualitative—were also collected from the
control village with a similar sample. Stakeholders’ interviews were audio-recorded, transcribed by an
independent transcription company, checked for accuracy, anonymised and imported into Nvivo11
software to facilitate qualitative data analysis according to RE-AIM framework.
4.4. Sample Size
While a sample size was not calculated (outcomes of interest were intervention and study design
feasibility and acceptability), previous studies have identified a minimum of 20 participants is required
to identify 95% of usability problems [47]. Although there is currently no published guidance as to the
sample size required for a pilot or feasibility trial and given that this pilot study employed a controlled
pre-and-post design (not a trial), we set the sample size to be 50 households per arm, which was higher
than the median among the published UK pilot trials [48]. This intervention was delivered at the
village rather than the individual level. In a full-scale study, village- or township-level randomisation
as part of a cluster trial would be appropriate. For this study, the feasibility of randomisation was
not tested.
4.5. Measures
The intervention aimed to reduce household antibiotic storage and improve safe antibiotic disposal;
this informed measure selection. The feasibility and acceptability of the selected study measures were
assessed to determine those most appropriate for a future cluster trial.
Primary measures: The primary objective was to describe antibiotic storage and disposal
behaviours. All respondents were asked whether, in the past month, they have: (a) Kept antibiotics at
home and (b) participated in the take-back programme.
Secondary measures included awareness and perceptions of the potential danger of “unsafe
disposal” and “non-prescription antibiotic use” on human and environmental health.
Process evaluation: Routine data on programme utilisation, costs, and in-kind expenses were
calculated. Returned antibiotics were stored in a pre-prepared bag with a pre-designed information sheet
including details of each collection, e.g., types and amount of the drugs received, and user’s satisfaction.
Data on participants’ socio-demographic characteristics including sex, age, education, income,
employment, and number of children in the household were also collected.
4.6. Data Analysis
Descriptive statistics (frequencies, means and standard deviations) were calculated for all variables.
Qualitative data were analysed using framework analysis. A priori codes were drawn from the interview
topic guide, study objectives, and feasibility evaluation framework. LL was the primary coder and
interpreted the data, along with two other coders, WXM and WWY. Consensus on themes and key
findings were reached through discussion.
5. Conclusions
This feasibility study presents an overall favourable public response toward a theory-driven,
community-based bartering market for antibiotic-take-back as a feasible, acceptable, and appropriate
intervention, warranting the expansion of the pilot programme. The proposed public-target intervention
can be an important component of a multifaceted AMR strategy to decrease inappropriate antibiotic
use in the community, especially in low-and-middle income countries, including China.
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